This page contains various guidance documents and reference materials categorized by license type and audience.
Pharmacists
- Connecticut Drug Laws
- 2023 Drug Control Legislative Updates CE Presentation
- Vaccinations by Pharmacists and Pharmacy Technicians
- Warning Sticker Required for All Controlled Substances (11/30/2023)
- Pharmacists May Continue to Prescribe Naloxone (9/27/2023)
- Pharmacist Prescribing of Hormonal Contraceptive (10/16/2023)
- Mobile Pharmacy (7/5/2023)
- Nonlegend Drugs (Over-the-counter) in Vending Machines (7/20/2023)
- Safe Storage and Disposal of Prescription Medications - Public Act 22-81 requires pharmacies to post signage no later than January 1, 2023.
- Medication Shortage Guidance (4/16/2020)
- Electronic Prescribing of Controlled Substances (EPCS)
- Drug Control Division Inspection Forms
- USP <797> Inspection Forms
- Naloxone Prescribing
- Prescription Drug Drop Box Locations
- Applications
- Self and Family Controlled Substance Prescribing Restriction
- Perpetual Inventory and Monthly Reconciliation
- Certification Submission Form
- Epinephrine at Authorized Entities
- Controlled Substance Prescribing Guidance
- Refill Guidance 2020
- Hydrocodone Moves to Schedule II
Prescribers/Practitioners
- Information for Healthcare Providers: Talking to Patients About Cannabis Use
- Connecticut Laws Impacting Prescribing and Practice (8/11/2023)
- Electronic Prescribing of Controlled Substances (EPCS)
- DCP Guidance for Licensed Practitioners Sec 20-622
- Prescription Drug Drop Box Locations
- Applications
- Veterinary Prescribing Guidance for Compounded Medication
- Self and Family Controlled Substance Prescribing Restriction
- Guidance for Epinephrine at Public Schools
- Compounded Sterile Product Information
- Epinephrine at Authorized Entities
- Controlled Substance Prescribing Guidance
- Refill Guidance 2020
- Hydrocodone Moves to Schedule II (October 6, 2014)
Laboratories
Hospitals
- DCP Guidance for Licensed Practitioners Sec 20-622
- USP <797> Inspection Forms
- Certification Submission Form
- Controlled Substance Prescribing Guidance
- Refill Guidance 2020
Wholesalers/Distributors
Manufacturers
- APRN Expenditure Disclosure Form
- Pharmaceutical Marketing Firm Registration
- Expenditure Disclosure Form (Independent Practicing Advance Practice Registered Nurse)
- Applications
- Suspicious Order Monitoring
- Epinephrine at Authorized Entities
- Ban on the Sale of Synthetic Drug Products
Nursing Homes
Law Enforcement
Schools
Retailers
- Ban on the Sale of Synthetic Drug Products
- Retailer Advisory on the Sale of Imported Food and Drug Products